Does the media favor HNGE or GRDN?

In the previous week, Hinge Health had 9 more articles in the media than Guardian Pharmacy Services. MarketBeat recorded 11 mentions for Hinge Health and 2 mentions for Guardian Pharmacy Services. Guardian Pharmacy Services' average media sentiment score of 1.16 beat Hinge Health's score of 0.79 indicating that Guardian Pharmacy Services is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Hinge Health 6 Very Positive mention(s) 1 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Guardian Pharmacy Services 2 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Does the media prefer GRDN or CHE?

In the previous week, Chemed had 12 more articles in the media than Guardian Pharmacy Services. MarketBeat recorded 14 mentions for Chemed and 2 mentions for Guardian Pharmacy Services. Guardian Pharmacy Services' average media sentiment score of 1.16 beat Chemed's score of 1.06 indicating that Guardian Pharmacy Services is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Guardian Pharmacy Services 2 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Chemed 11 Very Positive mention(s) 1 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Does the media refer more to HIMS or GRDN?

In the previous week, Hims & Hers Health had 32 more articles in the media than Guardian Pharmacy Services. MarketBeat recorded 34 mentions for Hims & Hers Health and 2 mentions for Guardian Pharmacy Services. Guardian Pharmacy Services' average media sentiment score of 1.16 beat Hims & Hers Health's score of 0.29 indicating that Guardian Pharmacy Services is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Hims & Hers Health 7 Very Positive mention(s) 7 Positive mention(s) 10 Neutral mention(s) 4 Negative mention(s) 1 Very Negative mention(s) Neutral Guardian Pharmacy Services 2 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Does the media prefer GRDN or RDNT?

In the previous week, RadNet had 9 more articles in the media than Guardian Pharmacy Services. MarketBeat recorded 11 mentions for RadNet and 2 mentions for Guardian Pharmacy Services. RadNet's average media sentiment score of 1.70 beat Guardian Pharmacy Services' score of 1.16 indicating that RadNet is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Guardian Pharmacy Services 2 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive RadNet 10 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Very Positive

Guardian Pharmacy Services (GRDN) Competitors

$37.56 +0.26 (+0.70%)

As of 03:58 PM Eastern

Compare

GRDN vs. HNGE, CHE, HIMS, RDNT, and LFST

Should you buy Guardian Pharmacy Services stock or one of its competitors? Guardian Pharmacy Services's main competitors and comparable companies include Hinge Health (HNGE), Chemed (CHE), Hims & Hers Health (HIMS), RadNet (RDNT), and LifeStance Health Group (LFST). Companies are selected based on similarities in market, industry, and size. These companies are all part of the "healthcare services" industry.

How does Guardian Pharmacy Services compare to Hinge Health?

Hinge Health (NYSE:HNGE) and Guardian Pharmacy Services (NYSE:GRDN) are both healthcare companies, but which is the better business? We will contrast the two companies based on the strength of their earnings, valuation, institutional ownership, media sentiment, risk, profitability, dividends and analyst recommendations.

Hinge Health has a beta of 1.3, indicating that its share price is 30% more volatile than the broader market. Comparatively, Guardian Pharmacy Services has a beta of 0.1, indicating that its share price is 90% less volatile than the broader market.

Hinge Health has a net margin of 15.15% compared to Guardian Pharmacy Services' net margin of 4.50%. Hinge Health's return on equity of 51.60% beat Guardian Pharmacy Services' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Hinge Health	15.15%	51.60%	14.16%
Guardian Pharmacy Services	4.50%	29.97%	16.18%

In the previous week, Hinge Health had 9 more articles in the media than Guardian Pharmacy Services. MarketBeat recorded 11 mentions for Hinge Health and 2 mentions for Guardian Pharmacy Services. Guardian Pharmacy Services' average media sentiment score of 1.16 beat Hinge Health's score of 0.79 indicating that Guardian Pharmacy Services is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Hinge Health	6 Very Positive mention(s)	1 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Guardian Pharmacy Services	2 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Hinge Health currently has a consensus target price of $100.57, suggesting a potential upside of 11.10%. Guardian Pharmacy Services has a consensus target price of $43.83, suggesting a potential upside of 16.70%. Given Guardian Pharmacy Services' stronger consensus rating and higher possible upside, analysts clearly believe Guardian Pharmacy Services is more favorable than Hinge Health.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Hinge Health	1 Sell rating(s)	2 Hold rating(s)	14 Buy rating(s)	1 Strong Buy rating(s)	2.83
Guardian Pharmacy Services	0 Sell rating(s)	1 Hold rating(s)	8 Buy rating(s)	0 Strong Buy rating(s)	2.89

Guardian Pharmacy Services has higher revenue and earnings than Hinge Health. Guardian Pharmacy Services is trading at a lower price-to-earnings ratio than Hinge Health, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Hinge Health	$587.86M	12.42	-$528.26M	$1.28	70.72
Guardian Pharmacy Services	$1.45B	1.29	$49.22M	$1.03	36.47

Summary

Hinge Health beats Guardian Pharmacy Services on 9 of the 15 factors compared between the two stocks.

How does Guardian Pharmacy Services compare to Chemed?

Guardian Pharmacy Services (NYSE:GRDN) and Chemed (NYSE:CHE) are both healthcare companies, but which is the superior investment? We will contrast the two companies based on the strength of their media sentiment, valuation, dividends, profitability, risk, earnings, analyst recommendations and institutional ownership.

Guardian Pharmacy Services has a beta of 0.1, meaning that its share price is 90% less volatile than the broader market. Comparatively, Chemed has a beta of 0.51, meaning that its share price is 49% less volatile than the broader market.

95.9% of Chemed shares are owned by institutional investors. 33.0% of Guardian Pharmacy Services shares are owned by insiders. Comparatively, 3.3% of Chemed shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth.

Chemed has higher revenue and earnings than Guardian Pharmacy Services. Chemed is trading at a lower price-to-earnings ratio than Guardian Pharmacy Services, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Guardian Pharmacy Services	$1.45B	1.29	$49.22M	$1.03	36.47
Chemed	$2.53B	2.83	$265.24M	$19.91	27.54

Guardian Pharmacy Services presently has a consensus price target of $43.83, suggesting a potential upside of 16.70%. Chemed has a consensus price target of $530.75, suggesting a potential downside of 3.20%. Given Guardian Pharmacy Services' stronger consensus rating and higher possible upside, equities research analysts plainly believe Guardian Pharmacy Services is more favorable than Chemed.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Guardian Pharmacy Services	0 Sell rating(s)	1 Hold rating(s)	8 Buy rating(s)	0 Strong Buy rating(s)	2.89
Chemed	0 Sell rating(s)	5 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.17

Chemed has a net margin of 10.60% compared to Guardian Pharmacy Services' net margin of 4.50%. Chemed's return on equity of 31.77% beat Guardian Pharmacy Services' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Guardian Pharmacy Services	4.50%	29.97%	16.18%
Chemed	10.60%	31.77%	18.90%

In the previous week, Chemed had 12 more articles in the media than Guardian Pharmacy Services. MarketBeat recorded 14 mentions for Chemed and 2 mentions for Guardian Pharmacy Services. Guardian Pharmacy Services' average media sentiment score of 1.16 beat Chemed's score of 1.06 indicating that Guardian Pharmacy Services is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Guardian Pharmacy Services	2 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Chemed	11 Very Positive mention(s)	1 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Summary

Chemed beats Guardian Pharmacy Services on 10 of the 16 factors compared between the two stocks.

How does Guardian Pharmacy Services compare to Hims & Hers Health?

Hims & Hers Health (NYSE:HIMS) and Guardian Pharmacy Services (NYSE:GRDN) are both healthcare companies, but which is the better stock? We will contrast the two businesses based on the strength of their risk, dividends, earnings, media sentiment, profitability, analyst recommendations, institutional ownership and valuation.

Hims & Hers Health presently has a consensus price target of $32.50, suggesting a potential upside of 8.80%. Guardian Pharmacy Services has a consensus price target of $43.83, suggesting a potential upside of 16.70%. Given Guardian Pharmacy Services' stronger consensus rating and higher probable upside, analysts plainly believe Guardian Pharmacy Services is more favorable than Hims & Hers Health.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Hims & Hers Health	1 Sell rating(s)	11 Hold rating(s)	4 Buy rating(s)	0 Strong Buy rating(s)	2.19
Guardian Pharmacy Services	0 Sell rating(s)	1 Hold rating(s)	8 Buy rating(s)	0 Strong Buy rating(s)	2.89

Hims & Hers Health has a beta of 2.4, suggesting that its stock price is 140% more volatile than the broader market. Comparatively, Guardian Pharmacy Services has a beta of 0.1, suggesting that its stock price is 90% less volatile than the broader market.

63.5% of Hims & Hers Health shares are owned by institutional investors. 11.8% of Hims & Hers Health shares are owned by company insiders. Comparatively, 33.0% of Guardian Pharmacy Services shares are owned by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock is poised for long-term growth.

In the previous week, Hims & Hers Health had 32 more articles in the media than Guardian Pharmacy Services. MarketBeat recorded 34 mentions for Hims & Hers Health and 2 mentions for Guardian Pharmacy Services. Guardian Pharmacy Services' average media sentiment score of 1.16 beat Hims & Hers Health's score of 0.29 indicating that Guardian Pharmacy Services is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Hims & Hers Health	7 Very Positive mention(s)	7 Positive mention(s)	10 Neutral mention(s)	4 Negative mention(s)	1 Very Negative mention(s)	Neutral
Guardian Pharmacy Services	2 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Guardian Pharmacy Services has a net margin of 4.50% compared to Hims & Hers Health's net margin of -5.51%. Guardian Pharmacy Services' return on equity of 29.97% beat Hims & Hers Health's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Hims & Hers Health	-5.51%	-6.51%	-1.20%
Guardian Pharmacy Services	4.50%	29.97%	16.18%

Hims & Hers Health has higher revenue and earnings than Guardian Pharmacy Services. Hims & Hers Health is trading at a lower price-to-earnings ratio than Guardian Pharmacy Services, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Hims & Hers Health	$2.35B	2.97	$128.37M	-$0.63	N/A
Guardian Pharmacy Services	$1.45B	1.29	$49.22M	$1.03	36.47

Summary

Guardian Pharmacy Services beats Hims & Hers Health on 10 of the 16 factors compared between the two stocks.

How does Guardian Pharmacy Services compare to RadNet?

Guardian Pharmacy Services (NYSE:GRDN) and RadNet (NASDAQ:RDNT) are both healthcare companies, but which is the superior business? We will compare the two companies based on the strength of their dividends, analyst recommendations, earnings, risk, profitability, media sentiment, valuation and institutional ownership.

In the previous week, RadNet had 9 more articles in the media than Guardian Pharmacy Services. MarketBeat recorded 11 mentions for RadNet and 2 mentions for Guardian Pharmacy Services. RadNet's average media sentiment score of 1.70 beat Guardian Pharmacy Services' score of 1.16 indicating that RadNet is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Guardian Pharmacy Services	2 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
RadNet	10 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Very Positive

Guardian Pharmacy Services has higher earnings, but lower revenue than RadNet. RadNet is trading at a lower price-to-earnings ratio than Guardian Pharmacy Services, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Guardian Pharmacy Services	$1.45B	1.29	$49.22M	$1.03	36.47
RadNet	$2.04B	2.95	-$18.65M	-$0.27	N/A

Guardian Pharmacy Services has a beta of 0.1, suggesting that its stock price is 90% less volatile than the broader market. Comparatively, RadNet has a beta of 1.36, suggesting that its stock price is 36% more volatile than the broader market.

Guardian Pharmacy Services has a net margin of 4.50% compared to RadNet's net margin of -0.93%. Guardian Pharmacy Services' return on equity of 29.97% beat RadNet's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Guardian Pharmacy Services	4.50%	29.97%	16.18%
RadNet	-0.93%	2.61%	0.91%

Guardian Pharmacy Services presently has a consensus target price of $43.83, suggesting a potential upside of 16.70%. RadNet has a consensus target price of $88.00, suggesting a potential upside of 15.08%. Given Guardian Pharmacy Services' higher probable upside, research analysts clearly believe Guardian Pharmacy Services is more favorable than RadNet.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Guardian Pharmacy Services	0 Sell rating(s)	1 Hold rating(s)	8 Buy rating(s)	0 Strong Buy rating(s)	2.89
RadNet	1 Sell rating(s)	1 Hold rating(s)	5 Buy rating(s)	2 Strong Buy rating(s)	2.89

77.9% of RadNet shares are owned by institutional investors. 33.0% of Guardian Pharmacy Services shares are owned by insiders. Comparatively, 5.1% of RadNet shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company is poised for long-term growth.

Summary

Guardian Pharmacy Services beats RadNet on 9 of the 16 factors compared between the two stocks.

How does Guardian Pharmacy Services compare to LifeStance Health Group?

LifeStance Health Group (NASDAQ:LFST) and Guardian Pharmacy Services (NYSE:GRDN) are both healthcare companies, but which is the better investment? We will contrast the two companies based on the strength of their earnings, dividends, media sentiment, risk, valuation, profitability, analyst recommendations and institutional ownership.

In the previous week, LifeStance Health Group had 5 more articles in the media than Guardian Pharmacy Services. MarketBeat recorded 7 mentions for LifeStance Health Group and 2 mentions for Guardian Pharmacy Services. Guardian Pharmacy Services' average media sentiment score of 1.16 beat LifeStance Health Group's score of 0.99 indicating that Guardian Pharmacy Services is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
LifeStance Health Group	4 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Positive
Guardian Pharmacy Services	2 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

LifeStance Health Group has a beta of 1.14, indicating that its share price is 14% more volatile than the broader market. Comparatively, Guardian Pharmacy Services has a beta of 0.1, indicating that its share price is 90% less volatile than the broader market.

LifeStance Health Group presently has a consensus price target of $12.38, suggesting a potential upside of 1.85%. Guardian Pharmacy Services has a consensus price target of $43.83, suggesting a potential upside of 16.70%. Given Guardian Pharmacy Services' stronger consensus rating and higher possible upside, analysts clearly believe Guardian Pharmacy Services is more favorable than LifeStance Health Group.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
LifeStance Health Group	0 Sell rating(s)	4 Hold rating(s)	6 Buy rating(s)	1 Strong Buy rating(s)	2.73
Guardian Pharmacy Services	0 Sell rating(s)	1 Hold rating(s)	8 Buy rating(s)	0 Strong Buy rating(s)	2.89

85.5% of LifeStance Health Group shares are owned by institutional investors. 3.5% of LifeStance Health Group shares are owned by insiders. Comparatively, 33.0% of Guardian Pharmacy Services shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company is poised for long-term growth.

Guardian Pharmacy Services has higher revenue and earnings than LifeStance Health Group. Guardian Pharmacy Services is trading at a lower price-to-earnings ratio than LifeStance Health Group, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
LifeStance Health Group	$1.42B	3.31	$9.66M	$0.13	93.46
Guardian Pharmacy Services	$1.45B	1.29	$49.22M	$1.03	36.47

Guardian Pharmacy Services has a net margin of 4.50% compared to LifeStance Health Group's net margin of 3.19%. Guardian Pharmacy Services' return on equity of 29.97% beat LifeStance Health Group's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
LifeStance Health Group	3.19%	3.39%	2.33%
Guardian Pharmacy Services	4.50%	29.97%	16.18%

Summary

Guardian Pharmacy Services beats LifeStance Health Group on 11 of the 17 factors compared between the two stocks.

Get Guardian Pharmacy Services News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding GRDN and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

GRDN vs. The Competition

Export

Metric	Guardian Pharmacy Services	Healthcare Providers & Services Industry	Healthcare Sector	NYSE Exchange
Market Cap	$1.86B	$9.99B	$7.40B	$24.35B
Dividend Yield	N/A	2.55%	2.53%	3.70%
P/E Ratio	36.47	35.18	272.19	30.13
Price / Sales	1.29	5.08	631.92	20.85
Price / Cash	29.61	130.07	79.89	33.34
Price / Book	7.26	4.12	13.14	7.69
Net Income	$49.22M	$312.92M	$3.47B	$1.07B
7 Day Performance	-1.00%	0.95%	1.38%	-0.21%
1 Month Performance	-7.12%	2.29%	8.62%	2.84%
1 Year Performance	44.07%	17.33%	25.90%	14.58%

Guardian Pharmacy Services Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
GRDN Guardian Pharmacy Services	3.3123 of 5 stars	$37.56 +0.7%	$43.83 +16.7%	+41.9%	$1.86B	$1.45B	36.47	3,600	Positive News
HNGE Hinge Health	3.8572 of 5 stars	$88.47 +0.3%	$100.57 +13.7%	+62.7%	$7.12B	$587.86M	69.12	1,437	Insider Trade
CHE Chemed	3.3229 of 5 stars	$535.86 +1.3%	$530.75 -1.0%	+19.1%	$6.92B	$2.53B	26.91	15,811	Positive News Insider Trade
HIMS Hims & Hers Health	2.3116 of 5 stars	$31.03 +13.3%	$32.43 +4.5%	-26.3%	$6.39B	$2.35B	N/A	2,442	Trending News Analyst Forecast Gap Down
RDNT RadNet	3.6629 of 5 stars	$75.54 +2.3%	$88.00 +16.5%	+10.4%	$5.81B	$2.04B	N/A	11,264	Positive News

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NYSE:GRDN) was last updated on 8/26/2026 by MarketBeat.com Staff.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Guardian Pharmacy Services (GRDN) Competitors

GRDN vs. HNGE, CHE, HIMS, RDNT, and LFST

How does Guardian Pharmacy Services compare to Hinge Health?

Summary

How does Guardian Pharmacy Services compare to Chemed?

Summary

How does Guardian Pharmacy Services compare to Hims & Hers Health?

Summary

How does Guardian Pharmacy Services compare to RadNet?

Summary

How does Guardian Pharmacy Services compare to LifeStance Health Group?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

GRDN vs. The Competition

Guardian Pharmacy Services Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Guardian Pharmacy Services (GRDN) Competitors

GRDN vs. HNGE, CHE, HIMS, RDNT, and LFST

How does Guardian Pharmacy Services compare to Hinge Health?

Which has more volatility & risk, HNGE or GRDN?

Is HNGE or GRDN more profitable?

Does the media favor HNGE or GRDN?

Do analysts recommend HNGE or GRDN?

Which has better earnings & valuation, HNGE or GRDN?

Summary

How does Guardian Pharmacy Services compare to Chemed?

Which has more risk & volatility, GRDN or CHE?

Do insiders and institutionals hold more shares of GRDN or CHE?

Which has better earnings & valuation, GRDN or CHE?

Do analysts recommend GRDN or CHE?

Is GRDN or CHE more profitable?

Does the media prefer GRDN or CHE?

Summary

How does Guardian Pharmacy Services compare to Hims & Hers Health?

Do analysts prefer HIMS or GRDN?

Which has more volatility & risk, HIMS or GRDN?

Do institutionals & insiders hold more shares of HIMS or GRDN?

Does the media refer more to HIMS or GRDN?

Is HIMS or GRDN more profitable?

Which has stronger earnings and valuation, HIMS or GRDN?

Summary

How does Guardian Pharmacy Services compare to RadNet?

Does the media prefer GRDN or RDNT?

Which has higher valuation & earnings, GRDN or RDNT?

Which has more volatility and risk, GRDN or RDNT?

Is GRDN or RDNT more profitable?

Do analysts rate GRDN or RDNT?

Do institutionals & insiders hold more shares of GRDN or RDNT?

Summary

How does Guardian Pharmacy Services compare to LifeStance Health Group?

Does the media favor LFST or GRDN?

Which has more risk & volatility, LFST or GRDN?

Do analysts rate LFST or GRDN?

Do insiders & institutionals hold more shares of LFST or GRDN?

Which has higher earnings & valuation, LFST or GRDN?

Is LFST or GRDN more profitable?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

GRDN vs. The Competition

Guardian Pharmacy Services Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools